Minisymposium

Immuno-Oncology: Advances in Translating from Bench to Clinic


Speakers: Luis Borges, Deborah Charych, Ravi Majeti, Brian Wong, Juan Jaen, Tara Arvedson, Jason DeVoss, Lelia Delamarre, Cheng Liu
Organizers: Snow Ge (Nektar), Deborah Charych (Nektar), Wenfeng Xu (Genentech)
Date: 6/28/2017
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; Students & Unemployed: $35;
Location: Crowne Plaza, Foster City, CA
Major Sponsor: (2)Celerion; Charles River
Vendor show vendors registered to date: (23)Applied BioMath; Aragen Bioscience, Inc.; BioLegend; Bio-Techne; Cardinal Health; Cellular Dynamics Intl; Covance; CrownBio; Cytovier LLC; DiscoveRx; Eurofins; Fujifilm Diosynth Biotechnologies; Intertek; PeproTech Inc; PharmaLegacy; PHARMout Laboratories; PPD; Premier Research; Quintara; Science Exchange; Second Genome; ThermoFisher; WuXi Apptec
Registration: http://www.PBSS.org
Registration deadline:6/27/2017  (it will close sooner if the seating cap is reached)

About the Topic

8:45-8:55  Opening Remarks and Introduction

8:55-9:35  Discovery of new drug targets and therapeutic approaches for cancer immunotherapy (Luis Borges, SVP, Five Prime Therapeutics)

9:35-10:15  Harnessing the Potent IL2 Immune Stimulatory Pathway with Designer Polymers (Deborah Charych, ED, Nektar)

10:15-10:25  Major sponsor presentation (Charles River)

10:25-10:40  Break

10:40-11:20  Pre-Clinical Development of a Humanized Anti-CD47 Antibody (Ravi Majeti, Professor, Stanford)

11:20-12:00  Discovery and development of orally-available cancer immunotherapies (Brian Wong, CEO, FLX Bio)

12:00-1:00  Lunch

1:00-1:40  Small Molecules, Antibodies, and Cell-based Therapies in the Fight Against Cancer (Juan Jaen, Founder and President, Arcus Biosciences and PACT Pharma)

1:40-2:20  Blincyto and BiTE® Antibody Platform for Cancer Therapy (Tara Arvedson, Principal Scientist, Amgen)

2:20-2:30  Major sponsor presentation (Celerion)

2:30-2:45  Break

2:45-3:25  T-VEC and oncolytic therapy (Jason DeVoss, Sr. Scientist, Amgen)

3:25-4:05  Personalized Cancer Vaccine (Lelia Delamarre, Sr. Scientist, Genentech)

4:05-4:15  Break

4:15-4:55  After CD19: CAR-T for solid tumor (Cheng Liu, CEO, Eureka)

4:55-5:15  General Q&A


2017-07-28, Developing Relevant Human Neural In Vitro Assays for CNS Safety Assessment and Drug Discovery: Challenges and Perspectives
2017-09-13, Unique Clinical Pharmacology & Biopharmaceutics Properties of Vyxeos: Development of a Nano-scale Fixed-ratio Cytarabine/Daunorubicin Liposomal Formulation for Acute Myeloid Leukemia
2017-10-11, Immunogenicity of Biologic Therapeutics
2017-10-24, Good Manufacturing Practices (GMPs) from R&D through Commercialization: Fundamentals, Regulatory Trends and Best Practices
2017-10-24, Good Laboratory Practices (GLPs): Fundamentals, Regulatory Trends and Best Practices
©Pharmaceutical & BioScience Society, International; Last Modified: 6/26/2017; Visited: 458914; Admin Logon

Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Simulations Plus Open positions available on our GastroPlus™ teams. Looking for both software developers and PBPK modelers. Apply online today!
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact: kelvin.lam@reactionbiology.com
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Simulations Plus GastroPlus™ developers launch PKPlus™. Generate validated PK reports for regulatory submissions. Value pricing/licensing. Request an evaluation today.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
Simulations Plus The new ADMET Predictor™ 8.1 provides #1-rated ADME-Tox predictions with improved performance for large libraries. Request an evaluation today!
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.

Submit a Text Ad